Post-BIO ins and outs: Rentschler and Syngene CEO appointments among big moves
By
Josh Abbott
5d agoen
Source
bioprocessintl.comPost-BIO ins and outs: Rentschler and Syngene CEO appointments among big movesbioprocessintl.comSymeres and Axxam also join the fray, choosing a new CSO to lead their scientific strategy.
You might also wanna read
Recent moves of note in and around the biotech and pharma industries
nature.com·12d ago
A turning point for pancreatic cancer patients
statnews.com·1mo ago
STAT+: Four major biotech updates to catch up on
STAT·1d ago
STAT+: Roche drug sets new standard for KRAS-driven lung cancer
STAT·5d ago
How AI Will Transform Biopharma: The Sequence of Change Matters
Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco
a16z.news·16d ago
Daikin Applied Announces New Top Leadership
HARDI·5d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.